THAP11 is a 34–44 kDa protein characterized by its DNA-binding THAP domain, which regulates transcriptional processes. It functions as a tumor suppressor by repressing c-Myc expression, influencing cell proliferation, apoptosis, and cell cycle arrest . The protein is ubiquitously expressed in normal tissues but is frequently downregulated in cancers such as hepatocellular carcinoma (HCC), colon cancer, and gastric cancer .
THAP11 antibodies are used in various experimental techniques to detect and quantify the protein in cellular and tissue samples. Key applications include:
THAP11 antibodies have enabled critical insights into its role in cancer biology and transcriptional regulation:
Tumor Suppression: Overexpression of THAP11 inhibits cancer cell growth by downregulating c-Myc, a proto-oncogene . Antibodies confirmed that THAP11 knockdown increases c-Myc expression and promotes proliferation in gastric cancer cells .
Tissue-Specific Expression: IHC studies revealed elevated THAP11 levels in colon cancer metastases , while WB detected its downregulation in gastric cancer tissues .
Transcriptional Regulation: Co-immunoprecipitation assays using THAP11 antibodies identified its interaction with HCF-1, a coregulator of gene expression .